References 1.Griswold M.G., Fullman N., Hawley C., Arian N., Zimsen S.R.M., Tymeson H.D., Venkateswaran V., Tapp A.D., Forouzanfar M.H., Salama J.S., et al
In TCA group, there were 16 patients (45.7%) with hand lesion and 19 patients (54.3%) with foot lesion compared to 17 patients (48.6%) with hand lesion and 18 patients (51.4%) with foot lesions among the methoxsalen group (Tables 1 and 2)
Medical weight loss can support more than confidence, it can support long-term health
14%, respectively)
These symptoms are often temporary and improve as the body adjusts.* Medical Monitoring Recommended: Regular follow-up with your healthcare provider is important to monitor progress, evaluate tolerance, and optimize your wellness plan while using GLP-1/GIP therapy.* Not Appropriate for Everyone: GLP-1/GIP therapy may not be suitable for individuals with certain medical conditions including a history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, or severe gastrointestinal disorders
Address common side effects like nausea, constipation, and fatigue while supporting muscle retention during weight loss
